MAP Policy

Timeline Longevity, Inc. Minimum Advertised Price (MAP) and Authorized Reseller Policy

Applies To: All authorized healthcare practitioners, clinics, distributors, and resellers of Timeline Longevity, Inc. products (“Products”)

1. Purpose

Timeline Longevity, Inc. has established this Minimum Advertised Price (MAP) and Authorized Reseller Policy to protect the integrity of its healthcare practitioner channel, preserve fair competition, and maintain the premium positioning and scientific credibility of its brand.This policy applies to all Timeline Longevity nutrition supplements and skincare products offered through the healthcare practitioner channel.

2. Scope

This policy governs all online advertising, promotion, and resale activities. It applies to any public-facing communication that references or promotes Timeline Longevity products, including but not limited to:

  • Practitioner or clinic websites and e-commerce platforms
  • Online marketplaces and retail websites
  • Social media, digital advertising, email campaigns, and paid search

3. Minimum Advertised Price (MAP)

  • The Minimum Advertised Price (MAP) for all Timeline Longevity products shall be no lower than the current Suggested Retail Price (SRP) published on the official Timeline Practitioner Website (pro.timeline.com).
  • The SRP serves as the reference point for MAP compliance and may be updated periodically at Timeline Longevity’s discretion.
  • Practitioners and resellers may sell products at any price privately, but may not publicly advertise or display a price below the published SRP online.
  • “Advertising” includes any public reference to pricing prior to checkout, including website listings, email promotions, or social media posts.
  • Private, password-protected portals or direct patient communications are exempt from this policy.

4. Marketplace and Advertising Restrictions

To preserve the integrity of the Timeline Longevity brand and ensure a consistent experience for patients and consumers, the following activities are strictly prohibited:

4.1 Online Marketplaces

Authorized sellers may not sell, resell, or offer Timeline Longevity products on any third-party marketplace, including but not limited to:

  • Amazon, eBay, Walmart.com, Etsy, Alibaba, or any similar platform.
  • Any unapproved storefront or intermediary marketplace not directly owned and operated by the authorized practitioner or clinic.

Violation of this clause will result in immediate termination of reseller privileges.

4.2 Digital Advertising and Paid Search

Authorized resellers may not:

  • Bid on or purchase Timeline Longevity trademarks, brand names, or product names (including “Timeline,” “Mitopure,” “Urolithin A,” and “Timeline Skin”) as keywords on Google Ads, Bing Ads, Meta Ads, or similar platforms.
  • Run digital advertising campaigns that compete with or undercut Timeline Longevity’s own paid marketing efforts.
  • Use unauthorized creative assets, brand logos, or trademarked materials in advertising or marketing content.

5. Bundling, Promotions, and Discounts

  • Products may not be advertised online in bundles, promotions, or “buy-more-save-more” offers that effectively reduce the advertised value of any individual product below the MAP.
  • Public coupon codes, sitewide sales, or loyalty programs that lower the displayed price below MAP are not permitted.
  • Private, non-public promotions such as in-clinic discounts, subscription pricing, or patient-specific offers are allowed.
  • The use of language such as “Call for Price” or “Login for Professional Pricing” is acceptable in place of a public price.

6. Enforcement

Timeline Longevity, Inc. actively monitors public pricing and advertising practices for compliance. Violations will result in the following actions:

  1. First Violation: Written notice and requirement to correct within 2 business days.
  2. Second Violation or Marketplace Violation: Immediate termination of reseller account and loss of authorized status.

Timeline Longevity, Inc. reserves the right to interpret, enforce, and modify this policy at its sole discretion.

7. Policy Administration

This policy is unilateral and non-negotiable, applying equally to all authorized practitioners, clinics, and distributors. No employee, agent, or representative of Timeline Longevity, Inc. has authority to modify or grant exceptions to this policy.

8. Contact

Questions or reports of potential violations may be directed to:
Email: hcp@timeline.com
Subject Line: “MAP Policy Inquiry”

Life-Altering Science™

Shop

Longevity Pro Capsules

Learn

ResourcesEvents

Support

Help Centerhcp@timeline.com+1 888-631-3359

Sign up for our newsletter

Sign up for our newsletter

By signing up, you agree to our privacy policy

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

a. Clinical studies consistently find improvements in muscle strength and endurance in a varied subset of the population ranging from resistance-trained athletes in their 20s to middle-aged adults with an average BMI of 29.52.

b. Our clinical studies showed that sedentary adults aged 65–90 improved muscle endurance, measured as leg and hand repetitions to fatigue, after daily supplementation with 1,000 mg Mitopure®.

c. Our randomized, placebo-controlled clinical study showed that supplementation with Mitopure® 1,000 mg for 4 weeks was associated with improvements in mitochondrial health of immune cells, favorable shifts in T-cell populations (including naïve cells), and markers of healthy immune function, in healthy, middle-aged adults.

d. Our clinical study showed that trained runners reported lower rate of perceived exertion (RPE) after a 3000 m time trial after 4 weeks of daily supplementation with 1,000 mg Mitopure®, and lower creatine kinase (CK) levels at 1 and 24 hours post-exercise, compared with placebo.

1. Ryu D, Mouchiroud L, Andreux PA, et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med. 2016;22(8):879-888.

2. Andreux PA, Blanco-Bose W, Ryu D, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab. 2019;1(6):595-603.

3. Denk D, Singh A, Kasler HG, et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nat Aging. 2025;5(11):2309-2322.

4. Monsalve Acevedo A, Sanctuary C, Aitken RJ, Wilkins A, Harrison N, Naughton M. Effects of Urolithin A supplementation on performance and antioxidant status in academy soccer players during preseason: a pilot randomised controlled trial. Front Nutr. 2025;12.

5. Liu S, D’Amico D, Shankland E, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(1):e2144279.

6. Zhao H, Zhu H, Yun H, et al. Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training: an 8-week randomized, double-blind, placebo-controlled study. J Int Soc Sports Nutr. 2024;21(1):2419388.

7. Singh A, D’Amico D, Andreux PA, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med. 2022;3(5).

8. Amazentis SA. A Confirmatory, Randomised, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Effects of a Dietary Supplement Containing Urolithin A (Mitopure®) on Muscle Strength and Performance in Healthy Middle-Aged Adults. clinicaltrials.gov; 2025. Accessed December 17, 2025.

© 2026
Terms & ConditionsPrivacy PolicyMAP Policy